Evaluation of restless legs syndrome and sleep disorders in patients with psoriatic arthritis

dc.contributor.authorSandikci, S. C.
dc.contributor.authorColak, S.
dc.contributor.authorBaykara, R. Aydogan
dc.contributor.authorOktem, A.
dc.contributor.authorCure, E.
dc.contributor.authorOmma, A.
dc.contributor.authorKucuk, A.
dc.date.accessioned2024-02-23T13:43:47Z
dc.date.available2024-02-23T13:43:47Z
dc.date.issued2019
dc.departmentNEÜen_US
dc.description.abstractObjectives. Restless legs syndrome (RLS) is a neurological disease with a chronic course that is characterised by sleep disorders and sensorimotor impairment. The aim of this study was to evaluate the prevalence and severity of RLS in psoriatic arthritis (PSA) patients and those with psoriasis (P). Patients and methods. The study included 50 patients with psoriasis (28 females, 22 males), 50 PSA patients (33 females, 17 males) and 50 healthy control subjects (34 females, 16 males), and all 3 groups were matched with respect to age, gender and body mass index (BMI). Evaluations were made using the International RLS Rating Scale, Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale, Insomnia Severity Index, Fatigue Severity Scale (FSS), Beck Depression Index (BDI) and the SF-36 quality of life scores. Results. RLS was determined at a higher rate in the PSA patients (64.0%), compared to the P group (20.0%, p< 0.001) and the control group (14.0%, p< 0.001). The number of moderate and severe RLS cases was significantly higher in the PSA group (68.7%) compared to the P group (30%, p< 0.001) and the control group (0%, p< 0.001). In regression analysis, an independent correlation was found between the RLS score and PSQI (beta [beta]= 0.269, p= 0.002), FSS (beta= 0.243, p= 0.003), SF-36 physical score (beta= 0.242, p= 0.004) and BDI (beta= 0.177, p= 0.036). Conclusion. RLS was determined in PSA patients at a higher rate than in psoriasis patients. The presence of RLS in PSA and psoriasis patients is related to impairments in sleep and quality of life, fatigue and depression.en_US
dc.identifier.doi10.1007/s00393-018-0562-y
dc.identifier.endpage995en_US
dc.identifier.issn0340-1855
dc.identifier.issn1435-1250
dc.identifier.issue10en_US
dc.identifier.pmid30421034en_US
dc.identifier.scopus2-s2.0-85056329030en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage987en_US
dc.identifier.urihttps://doi.org/10.1007/s00393-018-0562-y
dc.identifier.urihttps://hdl.handle.net/20.500.12452/10921
dc.identifier.volume78en_US
dc.identifier.wosWOS:000508433800019en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofZeitschrift Fur Rheumatologieen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInsomniaen_US
dc.subjectLeg Movementsen_US
dc.subjectSleep Disturbanceen_US
dc.subjectPsoriasisen_US
dc.subjectPsoriatic Arthritisen_US
dc.titleEvaluation of restless legs syndrome and sleep disorders in patients with psoriatic arthritisen_US
dc.typeArticleen_US

Dosyalar